Thyroid Cancer:
Because of its relative rarity and favorable outcome, it has not been feasible to assess medical interventions for thyroid cancer using randomized prospective trials. The approach to diagnosis and treatment relies to a great extent on information derived from retrospective studies. Overall prognosis...
Saved in:
| Other Authors: | |
|---|---|
| Format: | Electronic eBook |
| Language: | English |
| Published: |
Boston, MA
Springer US
1998
|
| Series: | Endocrine Updates
2 |
| Subjects: | |
| Online Access: | UBR01 Volltext |
| Summary: | Because of its relative rarity and favorable outcome, it has not been feasible to assess medical interventions for thyroid cancer using randomized prospective trials. The approach to diagnosis and treatment relies to a great extent on information derived from retrospective studies. Overall prognosis and survival rates have been edging upward over the past two decades. This is attributed to a wider acceptance of total thyroidectomy as the primary surgical strategy. The appropriate indication of radioiodine therapy remains controversial, and physicians must be familiar with staging criteria to make educated decisions. We are now beginning to understand the genetic mechanisms of thyroid tumor initiation and progression. There are still major challenges ahead. Thyroid Cancer provides comprehensive updates on the epidemiology, pathogenesis, diagnosis and treatment of thyroid neoplasms. Although the material should be of particular interest to scholars in the field, the contributors have striven to make it of practical use to physicians who treat patients with thyroid disease |
| Physical Description: | 1 Online-Ressource (XII, 360 p) |
| ISBN: | 9781461549451 |
| DOI: | 10.1007/978-1-4615-4945-1 |
Staff View
MARC
| LEADER | 00000nmm a2200000zcb4500 | ||
|---|---|---|---|
| 001 | BV046145827 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 190905s1998 |||| o||u| ||||||eng d | ||
| 020 | |a 9781461549451 |9 978-1-4615-4945-1 | ||
| 024 | 7 | |a 10.1007/978-1-4615-4945-1 |2 doi | |
| 035 | |a (ZDB-2-SME)978-1-4615-4945-1 | ||
| 035 | |a (OCoLC)1118993375 | ||
| 035 | |a (DE-599)BVBBV046145827 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 | ||
| 082 | 0 | |a 616.462 |2 23 | |
| 082 | 0 | |a 616.46 |2 23 | |
| 084 | |a XH 6250 |0 (DE-625)152926:13129 |2 rvk | ||
| 245 | 1 | 0 | |a Thyroid Cancer |c edited by James A. Fagin |
| 264 | 1 | |a Boston, MA |b Springer US |c 1998 | |
| 300 | |a 1 Online-Ressource (XII, 360 p) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Endocrine Updates |v 2 | |
| 520 | |a Because of its relative rarity and favorable outcome, it has not been feasible to assess medical interventions for thyroid cancer using randomized prospective trials. The approach to diagnosis and treatment relies to a great extent on information derived from retrospective studies. Overall prognosis and survival rates have been edging upward over the past two decades. This is attributed to a wider acceptance of total thyroidectomy as the primary surgical strategy. The appropriate indication of radioiodine therapy remains controversial, and physicians must be familiar with staging criteria to make educated decisions. We are now beginning to understand the genetic mechanisms of thyroid tumor initiation and progression. There are still major challenges ahead. Thyroid Cancer provides comprehensive updates on the epidemiology, pathogenesis, diagnosis and treatment of thyroid neoplasms. Although the material should be of particular interest to scholars in the field, the contributors have striven to make it of practical use to physicians who treat patients with thyroid disease | ||
| 650 | 4 | |a Diabetes | |
| 650 | 4 | |a Oncology | |
| 650 | 4 | |a Internal Medicine | |
| 650 | 4 | |a Cancer Research | |
| 650 | 4 | |a Diabetes | |
| 650 | 4 | |a Oncology | |
| 650 | 4 | |a Internal medicine | |
| 650 | 4 | |a Oncology | |
| 650 | 0 | 7 | |a Schilddrüsenkrebs |0 (DE-588)4140890-1 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 689 | 0 | 0 | |a Schilddrüsenkrebs |0 (DE-588)4140890-1 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Fagin, James A. |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9780792383260 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781461372448 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781461549468 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-1-4615-4945-1 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-2-SME | ||
| 940 | 1 | |q ZDB-2-SME_1990/2004 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-031526012 | ||
| 966 | e | |u https://doi.org/10.1007/978-1-4615-4945-1 |l UBR01 |p ZDB-2-SME |q ZDB-2-SME_1990/2004 |x Verlag |3 Volltext | |
Record in the Search Index
| _version_ | 1804180482983723008 |
|---|---|
| any_adam_object | |
| author2 | Fagin, James A. |
| author2_role | edt |
| author2_variant | j a f ja jaf |
| author_facet | Fagin, James A. |
| building | Verbundindex |
| bvnumber | BV046145827 |
| classification_rvk | XH 6250 |
| collection | ZDB-2-SME |
| ctrlnum | (ZDB-2-SME)978-1-4615-4945-1 (OCoLC)1118993375 (DE-599)BVBBV046145827 |
| dewey-full | 616.462 616.46 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.462 616.46 |
| dewey-search | 616.462 616.46 |
| dewey-sort | 3616.462 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| doi_str_mv | 10.1007/978-1-4615-4945-1 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02968nmm a2200565zcb4500</leader><controlfield tag="001">BV046145827</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">190905s1998 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781461549451</subfield><subfield code="9">978-1-4615-4945-1</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-1-4615-4945-1</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SME)978-1-4615-4945-1</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1118993375</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046145827</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.462</subfield><subfield code="2">23</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.46</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XH 6250</subfield><subfield code="0">(DE-625)152926:13129</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Thyroid Cancer</subfield><subfield code="c">edited by James A. Fagin</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Boston, MA</subfield><subfield code="b">Springer US</subfield><subfield code="c">1998</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (XII, 360 p)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Endocrine Updates</subfield><subfield code="v">2</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Because of its relative rarity and favorable outcome, it has not been feasible to assess medical interventions for thyroid cancer using randomized prospective trials. The approach to diagnosis and treatment relies to a great extent on information derived from retrospective studies. Overall prognosis and survival rates have been edging upward over the past two decades. This is attributed to a wider acceptance of total thyroidectomy as the primary surgical strategy. The appropriate indication of radioiodine therapy remains controversial, and physicians must be familiar with staging criteria to make educated decisions. We are now beginning to understand the genetic mechanisms of thyroid tumor initiation and progression. There are still major challenges ahead. Thyroid Cancer provides comprehensive updates on the epidemiology, pathogenesis, diagnosis and treatment of thyroid neoplasms. Although the material should be of particular interest to scholars in the field, the contributors have striven to make it of practical use to physicians who treat patients with thyroid disease</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Diabetes</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oncology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Internal Medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer Research</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Diabetes</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oncology </subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Internal medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oncology</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Schilddrüsenkrebs</subfield><subfield code="0">(DE-588)4140890-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Schilddrüsenkrebs</subfield><subfield code="0">(DE-588)4140890-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fagin, James A.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9780792383260</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781461372448</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781461549468</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-1-4615-4945-1</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SME</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SME_1990/2004</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-031526012</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-1-4615-4945-1</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-SME</subfield><subfield code="q">ZDB-2-SME_1990/2004</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
| genre_facet | Aufsatzsammlung |
| id | DE-604.BV046145827 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T08:36:28Z |
| institution | BVB |
| isbn | 9781461549451 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-031526012 |
| oclc_num | 1118993375 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | 1 Online-Ressource (XII, 360 p) |
| psigel | ZDB-2-SME ZDB-2-SME_1990/2004 ZDB-2-SME ZDB-2-SME_1990/2004 |
| publishDate | 1998 |
| publishDateSearch | 1998 |
| publishDateSort | 1998 |
| publisher | Springer US |
| record_format | marc |
| series2 | Endocrine Updates |
| spelling | Thyroid Cancer edited by James A. Fagin Boston, MA Springer US 1998 1 Online-Ressource (XII, 360 p) txt rdacontent c rdamedia cr rdacarrier Endocrine Updates 2 Because of its relative rarity and favorable outcome, it has not been feasible to assess medical interventions for thyroid cancer using randomized prospective trials. The approach to diagnosis and treatment relies to a great extent on information derived from retrospective studies. Overall prognosis and survival rates have been edging upward over the past two decades. This is attributed to a wider acceptance of total thyroidectomy as the primary surgical strategy. The appropriate indication of radioiodine therapy remains controversial, and physicians must be familiar with staging criteria to make educated decisions. We are now beginning to understand the genetic mechanisms of thyroid tumor initiation and progression. There are still major challenges ahead. Thyroid Cancer provides comprehensive updates on the epidemiology, pathogenesis, diagnosis and treatment of thyroid neoplasms. Although the material should be of particular interest to scholars in the field, the contributors have striven to make it of practical use to physicians who treat patients with thyroid disease Diabetes Oncology Internal Medicine Cancer Research Oncology Internal medicine Schilddrüsenkrebs (DE-588)4140890-1 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content Schilddrüsenkrebs (DE-588)4140890-1 s DE-604 Fagin, James A. edt Erscheint auch als Druck-Ausgabe 9780792383260 Erscheint auch als Druck-Ausgabe 9781461372448 Erscheint auch als Druck-Ausgabe 9781461549468 https://doi.org/10.1007/978-1-4615-4945-1 Verlag URL des Erstveröffentlichers Volltext |
| spellingShingle | Thyroid Cancer Diabetes Oncology Internal Medicine Cancer Research Oncology Internal medicine Schilddrüsenkrebs (DE-588)4140890-1 gnd |
| subject_GND | (DE-588)4140890-1 (DE-588)4143413-4 |
| title | Thyroid Cancer |
| title_auth | Thyroid Cancer |
| title_exact_search | Thyroid Cancer |
| title_full | Thyroid Cancer edited by James A. Fagin |
| title_fullStr | Thyroid Cancer edited by James A. Fagin |
| title_full_unstemmed | Thyroid Cancer edited by James A. Fagin |
| title_short | Thyroid Cancer |
| title_sort | thyroid cancer |
| topic | Diabetes Oncology Internal Medicine Cancer Research Oncology Internal medicine Schilddrüsenkrebs (DE-588)4140890-1 gnd |
| topic_facet | Diabetes Oncology Internal Medicine Cancer Research Oncology Internal medicine Schilddrüsenkrebs Aufsatzsammlung |
| url | https://doi.org/10.1007/978-1-4615-4945-1 |
| work_keys_str_mv | AT faginjamesa thyroidcancer |